Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
This study is looking into a new medicine called Vamifeport for adults who have a common genetic condition called hereditary hemochromatosis (HFE-HH). This condition causes too much iron to build up in the body, particularly in the liver. The main goal of the study is to find out if Vamifeport can help lower the iron levels in the liver, which will be measured using a special type of MRI scan. To get a clear picture, some participants will receive the new medicine, while others will receive a dummy pill (placebo). This helps researchers understand the true effect of Vamifeport compared to not having the active medicine. The study is in an early stage, called Phase 2, and will involve several medical checks.
A colpo d'occhio
Di cosa tratta questo studio?
This study is exploring a new medicine called Vamifeport for adults who have a condition known as hereditary hemochromatosis (HFE-HH). This is a genetic condition meaning it's passed down in families, and it causes the body to absorb too much iron from food. Over time, this extra iron can build up in organs like the liver, which can cause health problems if not managed.
The main purpose of this study is to see if Vamifeport can safely and effectively reduce the amount of iron stored in the liver. Researchers will use a special type of MRI scan to measure iron levels in the liver before and after treatment. They want to understand how well this new medicine works compared to a 'dummy' pill that contains no active medicine, which is called a placebo. By comparing these two groups, scientists can be more sure about the effects of Vamifeport itself.
This is a Phase 2 study, which means it's an early but important step in developing new medicines. It helps researchers gather more information about how the medicine works, what a good dose might be, and checks for any side effects. The results will help decide if this medicine should be tested in larger studies in the future.
Punti chiave
- This study tests a new medicine (Vamifeport) for iron overload in hereditary hemochromatosis.
- It aims to reduce liver iron levels, measured by special MRI scans.
- You might receive the new medicine or a dummy pill (placebo).
- Regular health checks, blood tests, and scans are part of participating.
- It's a Phase 2 study, an early step in medicine development.
- Puoi smettere di partecipare in qualsiasi momento.
Chi può essere idoneo?
To join this study, you need to be an adult, aged 18 or over, and have signed a form saying you understand the study and agree to take part. A doctor must have already diagnosed you with hereditary hemochromatosis (HFE-HH) in the past. We'll also need to see that you have too much iron in your body currently. This will be checked by blood tests showing specific iron levels and a special MRI scan of your liver showing iron buildup. Your body weight and height (BMI) also need to be within a certain healthy range.
There are also some reasons why you might not be able to join. For example, if you have other serious health problems, unusual blood test results, or heart issues that doctors think are important, you might not be eligible. This is to make sure the study is as safe as possible for everyone involved.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- Sei un adulto (18 anni o più)?
- Have you been diagnosed with hereditary hemochromatosis (HFE-HH)?
- Do your doctors think you have too much iron in your body currently?
- Do you have a healthy body weight for your height?
- Do you have any serious ongoing health problems that might make you ineligible?
Cosa comporta la partecipazione?
If you decide to take part, you'll be randomly assigned to one of two groups: one receiving the new medicine, Vamifeport, and the other receiving a dummy pill (placebo). Neither you nor your study doctor will know which you are receiving, which helps make the study fair. You'll take the study medicine or placebo regularly as instructed.
Throughout the study, you'll have several visits to the clinic. These visits will involve various health checks, blood tests, and liver MRI scans to measure your iron levels. There will also be appointments to check on your overall health and look for any changes or side effects. The total duration of your participation in the study will involve initial checks, the period of taking the study medicine, and a follow-up period after you stop taking it.
Rischi e benefici potenziali
Locations (100)
- Banner MD AndersonCodice postale verificatoGilbert, Stati Uniti
- Infinity Clinical TrialsCodice postale verificatoSan Diego, Stati Uniti
- Medical Oncology Associates of San DiegoCodice postale verificatoSan Diego, Stati Uniti
- Green Leaf Clinical TrialsCodice postale verificatoJacksonville, Stati Uniti
- Global Medical Research Management LLCCodice postale verificatoMiami, Stati Uniti
- Indiana University Health University HospitalCodice postale verificatoIndianapolis, Stati Uniti
- Ochsner Medical Complex - High GroveCodice postale verificatoBaton Rouge, Stati Uniti
- Johns Hopkins University School of MedicineCodice postale verificatoBaltimora, Stati Uniti
- American Oncology Partners, PA dba The Center for Cancer and Blood DisordersCodice postale verificatoBethesda, Stati Uniti
- James M. Stockman Cancer InstituteCodice postale verificatoFrederick, United States
- University of Michigan Health System (UMHS)Codice postale verificatoAnn Arbor, Stati Uniti
- Aspirus St. Luke's Clinic - Duluth - Oncology & HematologyCodice postale verificatoDuluth, United States
Domande comuni
What is hereditary hemochromatosis (HFE-HH)?
It's a genetic condition where your body absorbs and stores too much iron, which can build up in organs like the liver and cause health problems.
What is a 'dummy pill' or placebo?
A dummy pill looks exactly like the study medicine but doesn't contain any active ingredients. It helps researchers understand the true effect of the medicine being tested.
What does a liver MRI scan involve?
It's a special type of scan that uses strong magnets and radio waves to create detailed pictures of your liver, allowing doctors to precisely measure iron levels there.
Why is this called a 'Phase 2' study?
Phase 2 studies are early stages of drug development. They aim to see if a new medicine works, find a good dose, and check for safety in a larger group of people than initial tests.
Sapró se sto ricevendo il vero medicinale o il placebo?
No, during the study, neither you nor your study doctor will know whether you are receiving Vamifeport or the placebo. This is to ensure the study results are unbiased.
Come saperne di più
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.